AMCAR Home
Healthcare is the fundamental foundation of a civilized society, and the ability of the people the have accurate, reliable, and timely access to those systems is paramount to the general safety and security of our society. When providers, clinics, hospitals, laboratories, and other agencies involved in the healthcare systems do not have reliable access to a depenable supply of consumables that are crutial to their day-to-day operations, you will start to see delayed care which will ultimately lead to successive failures across the entire healthcare infrastructure.
Without a dependable source for reliable products, our Healthcare System will constantly struggled with continued supply chain issues. This is why AMCAR Scientific belives that the entire Healthcare Supply Chain should be considred a National Security interest, and re-shored to ensure that our providers, clinics, hospitals, laboratories, and other agenices all have access to what they need to provide better ptient care to all peoples.
The current Healthcare Systems have been operating using the same metrics, operational plans, and logistics for the better part of the last five decades. This includes how the supply chain has been slowly and systematically off-shored the manufacturing and production facilities that deliver critical goods and products that providers, clinicians, and patients depend on daily.
Consistent off-shoring that has taken place for more than four decades has lead to an over dependence on foreign powers that are now part of an ustable geo-political region where growing tensions with neighboring terratories are putting the reliability of the supply chain in jeapordy. Off-shoring combined with the continued after effects of the 2020 pandemic have lead to extreamly high strains on the availability of the products that are critical to the continued operations of our healthcare systems.
AMCAR Scientific has both short and long term plans that will take steps to start addressing the current and coming Healthcare Supply Chain logistic issues.
Threestrategic areas for expansion initiatives have been targeted for action over the next 3-5 years. Those initiatives include:
- Medical Consumables
- Bio-Chemicals, Assays, Reagents, and Targets
- Software and Hardare Technologies
AMCAR Scientific believes that these three initiatives are key to the creation of a solid foundation that the future of a new modern Healthcare Supply Chain will be built on.
AMCAR Scientific currently has site selection processes underway targeting locations in the Dallas, Texas; Phoenix, Arizona; and Tulsa, Oklahoma areas.
As the bulk of the products in our growing catalog must be producted in ISO Category 8 Clean rooms, we are targeting those areas Zoned Light Industrial with additional land for a 3-5 year growth plan that will include additoinal production, storage, and distribution areas.
We anticipate intial site selection announcements in late October, 2023.